List view / Grid view

Rigontec

Filter the results

 

news

Rigontec GmbH Appoints Dr. Christian Schetter as CEO

5 February 2015 | By Rigontec GmbH

Rigontec GmbH, a privately held biopharmaceutical company developing RNA-based immunotherapeutics for the treatment of cancer and viral diseases, announces the appointment of Dr. Christian Schetter as CEO...